Sitravatinib in combination with nivolumab demonstrates clinical activity in platinum-experienced patients with urothelial carcinoma (UC) who progressed on prior immune checkpoint inhibitor (CPI)Pavlos Msaouel,Arlene Siefker-Radtke,Randy Sweis,Amir Mortazavi,Nicholas Vogelzang,Ulka Vaishampayan, Thomas Bradley,Manojkumar Bupathi,Luke Nordquist,David Shaffer,Joel Picus,Jeffrey Yorio,Shifeng Mao, Gurjyot Doshi,Daniel Spitz, Sunil Gandhi,Daniel Chong,Arash Rezazadeh Kalebasty,James Christensen,Peter Olson,Demiana Faltaos,Ronald Shazer, Maria Winter,Delia Alvarez, Hirak Del-Torossian,Jonathan RosenbergJOURNAL FOR IMMUNOTHERAPY OF CANCER(2019)引用 3|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要